Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

More research is needed to better understand and treat Fibrosing Frontal Alopecia.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

Targeting the AhR pathway may help treat alopecia areata.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Diffuse alopecia areata causes widespread hair thinning due to an autoimmune response.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

Women with alopecia areata have poor blood flow, possibly due to nerve inflammation.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

These hair loss conditions might be part of a spectrum, not separate issues.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.